Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
Conclusions
DE is deliverable without increased adverse outcomes. Males have less myelosuppression during VDC, and should be especially considered for DE.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Hematology | Sarcomas | Statistics | Toxicology